✦ LIBER ✦

Pharmacovigilance in Europe

Book ID: 119065706
Publisher: The Lancet
Year: 1993
Tongue: English
Weight: 220 KB
Volume: 341
Category: Article
ISSN: 0140-6736
DOI: 10.1016/0140-6736(93)90721-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacovigilance in Europe and North Am

Pharmacovigilance in Europe and North America: Divergent approaches

✍ Mary Wiktorowicz; Joel Lexchin; Kathy Moscou 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Issues with pharmacovigilance in Eastern

Issues with pharmacovigilance in Eastern Europe countries: The industry perspective

✍ Ivana Hanzl Dujmovic; Ivana Starešinić Šernhorst 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 72 KB

La pharmacovigilance II. Le système fran

La pharmacovigilance II. Le système français dans la pharmacovigilance européenne

✍ Edith Albengres 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 195 KB

La pharmacovigilance europeenne associe les I~tats-membres dans un reseau decentralise de centres nationaux de pharmacovigilance dont I'activite est centralisee & Londres par un comite des specialites pharmaceutiques (CSP) sous I'autorite de I'Agence europeenne. Ce CSP gere directement les demandes

Strengthening and Rationalizing Pharmaco

Strengthening and Rationalizing Pharmacovigilance in the EU: Where is Europe Heading to?

✍ Dr John-Joseph Borg, George Aislaitner, Michal Pirozynski, Stephen Mifsud 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 135 KB

Improving pharmacovigilance in Europe: T

Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain

✍ Gurwitz, David; Rodríguez-Antona, Cristina; Payne, Katherine; Newman, William; G 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB

Pharmacovigilance in Poland

✍ Andrzej Czarnecki; Agata Maciejczyk 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

History and current status of monitoring of adverse drug reactions in Poland is presented. The Centre for Monitoring of Adverse Drug Reactions (ADR) was established in 1971. The number of suspected drug reactions reported varied in subsequent years. In the analysed periods of time 1972±1984 and 1985